Lowell Blake & Associates’s LeMaitre Vascular LMAT Stock Holding History

Lowell Blake & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,186	Closed	-$241K	–	57
2022 Q1	$241K	Hold	5,186	–	–	0.09%	52
2021 Q4	$260K	Sell	5,186 -3,458	-40%	-$179K	0.1%	51
2021 Q3	$459K	Hold	8,644	–	–	0.21%	42
2021 Q2	$527K	Hold	8,644	–	–	0.24%	42
2021 Q1	$422K	Hold	8,644	–	–	0.22%	41
2020 Q4	$350K	Hold	8,644	–	–	0.26%	35
2020 Q3	$281K	Hold	8,644	–	–	0.23%	45
2020 Q2	$228K	Sell	8,644 -2,218	-20%	-$58K	0.22%	47
2020 Q1	$271K	Hold	10,862	–	–	0.35%	44
2019 Q4	$390K	Buy	+10,862	New	+$375K	0.43%	40

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lowell Blake & Associates's LMAT Position: Q2 2022 in Review

Lowell Blake & Associates sold out of LeMaitre Vascular (LMAT) in Q2 2022, closing a stake of 5,186 shares — an estimated $241K sold.

Lowell Blake & Associates first reported a position in LMAT in Q4 2019 and held it in 10 quarters. The position peaked at $527K in Q2 2021. 179 funds tracked by Wall St. Rank hold LMAT as of Q2 2022.

Lowell Blake & Associates reported no remaining LeMaitre Vascular position as of Q2 2022 after selling out during the quarter.
Lowell Blake & Associates sold 5,186 LeMaitre Vascular shares in Q2 2022, an estimated $241K.
Lowell Blake & Associates first reported a position in LeMaitre Vascular in Q4 2019 and held it in 10 quarters.
Lowell Blake & Associates's LeMaitre Vascular position peaked at $527K in Q2 2021.
179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2022.

Based on Lowell Blake & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.